{"id":350,"date":"2018-11-29T01:22:25","date_gmt":"2018-11-29T01:22:25","guid":{"rendered":"http:\/\/www.tylerjford.com\/landing.html\/?p=350"},"modified":"2020-05-01T19:25:02","modified_gmt":"2020-05-01T19:25:02","slug":"when-an-effective-cancer-treatment-makes-your-cells-riot-cytokine-release-syndrome","status":"publish","type":"post","link":"https:\/\/www.tylerjford.com\/landing.html\/2018\/11\/29\/when-an-effective-cancer-treatment-makes-your-cells-riot-cytokine-release-syndrome\/","title":{"rendered":"When an Effective Cancer Treatment Makes Your Cells Riot: Cytokine Release Syndrome"},"content":{"rendered":"<body><p><\/p><span style=\"font-weight: 400;\">Researchers and doctors have found many effective ways to modify cancer patients\u2019 own immune cells and use them to attack cancer cells. They have been so successful that one type of these so-called \u201c<\/span><a href=\"http:\/\/www.tylerjford.com\/landing.html\/2018\/10\/31\/3-effective-cancer-immunotherapies\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">immunotherapies<\/span><\/a><span style=\"font-weight: 400;\">\u201d was even considered the \u201c<\/span><a href=\"https:\/\/www.asco.org\/research-progress\/reports-studies\/clinical-cancer-advances-2018\/advance-year\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Advance of the Year<\/span><\/a><span style=\"font-weight: 400;\">\u201d in 2018 by the American Society of Clinical Oncology. However, these therapies are not perfect. Some immunotherapies cause overactivation of the immune system, which can result in terrible side effects including damage to internal organs. Cumulatively, this overactivation and its side effects are known as cytokine release syndrome. Thankfully researchers are coming up with inventive ways to limit or stop cytokine release syndrome, which makes immunotherapies even more powerful.<\/span>\n<p><span style=\"font-weight: 400;\">Researchers don\u2019t yet fully understand all the specific activities that cause the dangerous overactivation of the immune system during immunotherapy. You can think of this overactivation as something like a riot or stampede of cells. When doctors give cancer patients modified immune cells, they do a fantastic job of killing cancer cells, but they also sound the alarm and throw out a bunch of signals saying \u201cSOMETHING NEEDS TO BE DONE!\u201d These signals activate other immune cells, those immune cells send out more signals, and then even non-immune cells can begin acting irregularly.<\/span><\/p>\n<figure id=\"attachment_351\" aria-describedby=\"caption-attachment-351\" style=\"width: 525px\" class=\"wp-caption aligncenter\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"wp-image-351 size-large\" src=\"https:\/\/i0.wp.com\/www.tylerjford.com\/wp-content\/uploads\/2018\/11\/Cellular-Riot-Caused-by-Immunotherapy.jpg?resize=525%2C402\" alt=\"Drawing a modified immune cell attacking a cancer cell and causing a riot\" width=\"525\" height=\"402\" loading=\"lazy\" srcset=\"https:\/\/i0.wp.com\/www.tylerjford.com\/wp-content\/uploads\/2018\/11\/Cellular-Riot-Caused-by-Immunotherapy.jpg?resize=1024%2C785&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.tylerjford.com\/wp-content\/uploads\/2018\/11\/Cellular-Riot-Caused-by-Immunotherapy.jpg?resize=300%2C230&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.tylerjford.com\/wp-content\/uploads\/2018\/11\/Cellular-Riot-Caused-by-Immunotherapy.jpg?resize=768%2C589&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.tylerjford.com\/wp-content\/uploads\/2018\/11\/Cellular-Riot-Caused-by-Immunotherapy.jpg?w=1575 1575w\" sizes=\"auto, (max-width: 525px) 100vw, 525px\" \/><figcaption id=\"caption-attachment-351\" class=\"wp-caption-text\">A cellular riot caused by a modified immune cell used to attack a cancer cell<\/figcaption><\/figure>\n<p><span style=\"font-weight: 400;\">This cellular rioting can lead to disruption of blood vessels, flu-like symptoms, and damage to organs; but, luckily, doctors know how to treat many of these things. Doctors can give patients drugs that will limit the negative side effects of the cellular riot and block some of the alarms. Nonetheless, these drugs aren\u2019t equally effective in all patients, and there is no one-size-fits-all treatment that can be used in every case.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Recognizing this issue, researchers are working to make it so the modified cells used in immunotherapy don\u2019t cause cellular riots. These researchers are further modifying the immune cells so that they send out fewer alarm signals in the first place and can be destroyed if a riot begins. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Importantly, even without these new modifications, immunotherapies are already very effective at treating cancers of the blood (read the <\/span><a href=\"https:\/\/www.asco.org\/research-progress\/reports-studies\/clinical-cancer-advances-2018\/advance-year\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Advance of the Year<\/span><\/a><span style=\"font-weight: 400;\"> article for more). I\u2019m hopeful that researchers will be able to make immunotherapies more effective against other types of cancers soon (think solid tumors), and the ability to control these cellular riots will be the icing on the immunotherapy cake. It\u2019s an exciting and hopeful time for cancer researchers and patients!<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>References<\/strong>:<\/span><\/p>\n<ol>\n<li><span style=\"font-weight: 400;\">Chakravarti, Deboki, and Wilson W. Wong. \u201cSynthetic biology in cell-based cancer immunotherapy.\u201d <\/span><i><span style=\"font-weight: 400;\">Trends in biotechnology<\/span><\/i><span style=\"font-weight: 400;\">33.8 (2015): 449-461. PubMed <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26088008\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">PMID: 26088008<\/span><\/a><span style=\"font-weight: 400;\">. PubMed Central <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4509852\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">PMCID: PMC4509852<\/span><\/a><span style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">.<\/span><\/span><\/li>\n<li><span style=\"font-weight: 400;\">Shimabukuro-Vornhagen, Alexander, et al. \u201cCytokine release syndrome.\u201d <\/span><i style=\"font-size: 1rem;\">Journal for immunotherapy of cancer<\/i><span style=\"font-weight: 400;\"> 6.1 (2018): 56. PubMed <\/span><a style=\"font-size: 1rem;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29907163\" target=\"_blank\" rel=\"noopener noreferrer\">PMID: 29907163<\/a><span style=\"font-weight: 400;\">. PubMed Central <\/span><a style=\"font-size: 1rem;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6003181\/\" target=\"_blank\" rel=\"noopener noreferrer\">PMCID: PMC6003181<\/a><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ol>\n<p><\/p>\n<\/body>","protected":false},"excerpt":{"rendered":"<p>Researchers and doctors have found many effective ways to modify cancer patients\u2019 own immune cells and use them to attack cancer cells. They have been so successful that one type of these so-called \u201cimmunotherapies\u201d was even considered the \u201cAdvance of the Year\u201d in 2018 by the American Society of Clinical Oncology. However, these therapies are &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.tylerjford.com\/landing.html\/2018\/11\/29\/when-an-effective-cancer-treatment-makes-your-cells-riot-cytokine-release-syndrome\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;When an Effective Cancer Treatment Makes Your Cells Riot: Cytokine Release Syndrome&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[21,6],"tags":[4,16,15],"class_list":["post-350","post","type-post","status-publish","format-standard","hentry","category-biology","category-science-communication","tag-biology","tag-cancer","tag-immunology"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pap2RX-5E","_links":{"self":[{"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/posts\/350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/comments?post=350"}],"version-history":[{"count":7,"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/posts\/350\/revisions"}],"predecessor-version":[{"id":831,"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/posts\/350\/revisions\/831"}],"wp:attachment":[{"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/media?parent=350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/categories?post=350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tylerjford.com\/landing.html\/wp-json\/wp\/v2\/tags?post=350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}